Investor Alert – Sevion Therapeutics
Are you concerned about your investment in Sevion Therapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Sevion Therapeutics, Inc. was acquired by Eloxx Pharmaceuticals Ltd. in a reverse merger transaction, as of December 19, 2017, according to Bloomberg. Sevion Therapeutics, a development-stage biotech company, builds and develops a portfolio of therapeutics for the treatment of cancer and immunological diseases. Under its new name, Eloxx Pharmaceuticals, Inc., the company began trading on OTCQB Market as of December 20, 2017.
Investigating Potential Claims
The White Law Group is investigating potential claims involving Sevion Therapeutics and the FINRA registered brokerage firms who may have unsuitably recommended it to investors.
Brokerage firms are required to perform due diligence on any offering they recommend. They must ensure that all recommendations made are suitable in light of the client’s age, investment experience, net worth, income, and investment objectives.
If a firm fails to perform due diligence or makes an unsuitable recommendation, the broker-dealer can be held responsible for any losses in a FINRA Arbitration claim.
FINRA Dispute Resolution is an arbitration venue for investors with claims against their brokerage firm or financial professional. It provides investors with an opportunity to attempt to recoup their investment losses without filing such claims in court.
If you are concerned about your investment in Sevion Therapeutics the securities attorneys at The White Law Group may be able to help you. For a free consultation to discuss your options, please call the offices of The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: Sevion Therapeutics complaints, Sevion Therapeutics help, Sevion Therapeutics high commissions, Sevion Therapeutics information, Sevion Therapeutics investigation, Sevion Therapeutics investment, Sevion Therapeutics investment losses, Sevion Therapeutics investor relations, Sevion Therapeutics investors, Sevion Therapeutics losses, Sevion Therapeutics ppm, Sevion Therapeutics prospectus, Sevion Therapeutics recovery options, Sevion Therapeutics risk, Sevion Therapeutics stock information, Sevion Therapeutics update Last modified: October 11, 2018